Press Room

JDRF in the Globe and Mail, November 5, 2014: Improving the odds for expectant mothers

JDRF showcases advancements in T1D pregnancy care; highlighting JDRF CCTN and the CONCEPTT Trial, and exploring the challenges of managing T1D through pregnancy.


40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes

40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes (T1D) JDRF Ambassadors head to Parliament Hill to discuss the importance of funding research


Canadian Post-doctoral Fellowships Awarded in type 1 diabetes Research

Lilly Canada provided JDRF with $220,000 in 2013-2014 in support of the creation of a national clinical training program to enable young investigators to further engage in medical research associated with type 1 diabetes.


Giant leap against diabetes

Ability to produce embryonic stem cells will allow researchers to push faster toward cure


Diabetes researchers find faster way to create insulin-producing cells

University of British Columbia, in collaboration with BetaLogics Venture, a division of Janssen Research & Development, LLC, has published a study highlighting a protocol to convert stem cells into insulin-producing cells. The new procedure could be an important step in the fight against Type 1 ...


Fighting diabetes one kick at a time

Sun Life Financial and the Canadian Football League (CFL) partner to raise up to $100,000 for JDRF


JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial

JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate.


JDRF Partner ViaCyte Announces Key Project Milestone

JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes


Novo Nordisk Commits $5 Million Grant Supporting JDRF Outreach Initiative

To address the need for education on how patients with type 1 diabetes (T1D) can pursue physical activity safely, Novo Nordisk has committed to a three-year, $5 million grant in support of a new JDRF Outreach initiative titled “T1D Performance in Exercise and Knowledge ...


JDRF and the Innovative Medicines Initiative Partner for Type 1 Diabetes Research

JDRF and the Innovative Medicines Initiative (IMI) have partnered on a new precompetitive type 1 diabetes research consortium entitled “TRANSLATIONAL APPROACHES TO DISEASE MODIFYING THERAPY OF TYPE 1 DIABETES MELLITUS (T1DM)”. 


Lets turn type one into type none